Cervical Cancer

Mar 1, 2012 Issue
Interventions to Increase Cervical Cancer Screening Rates [Cochrane for Clinicians]

Invitation letters are the most studied method of encouraging cervical cancer screening, and they are effective (relative risk [RR] = 1.44; 95% confidence interval [CI], 1.24 to 1.52).1–3 Invitation letters may be more cost-effective than more intensive recruitment efforts (e.g., telephone interview...

Dec 15, 2010 Issue
Bivalent HPV Recombinant Vaccine (Cervarix) for the Prevention of Cervical Cancer [STEPS]

Cervarix is effective in preventing known cytologic and histologic precursors of cervical cancer, although, as with Gardasil, it has not been shown to decrease rates of cervical cancer. This protection has been shown to last for six years, but it is unclear if a booster dose is needed.

Nov 15, 2010 Issue
Human Papillomavirus: Clinical Manifestations and Prevention [Article]

Human papillomaviruses cause the most common sexually trans- mitted infection in the world and are responsible for nearly all cases of cervical cancer. Genital human papillomavirus infection can be divided into low-risk infections (causing genital warts) and high-risk infections (causing cervical in...

Jun 1, 2010 Issue
ACOG Updates Guidelines on Cervical Cytology Screening [Practice Guidelines]

One approach to further reduce the incidence of cervical cancer is to increase screening rates among women who have never been screened or who are screened infrequently. The American College of Obstetricians and Gynecologists (ACOG) recently updated its recommendations on screening for cervical cancer, including screening intervals.

Jul 15, 2009 Issue
Update on ASCCP Consensus Guidelines for Abnormal Cervical Screening Tests and Cervical Histology [Article]

New data have emerged since publication of the American Society for Colposcopy and Cervical Pathology's 2001 consensus guidelines for management of abnormal cervical cytology and histology. The 2006 guidelines include recommendations for special populations (i.e., adolescents and pregnant women). Hu...

Jan 1, 2006 Issue
Management of Histologic Abnormalities of the Cervix [Article]

The American Society for Colposcopy and Cervical Pathology sponsored a consensus conference in 2001 to develop evidence-based guidelines for women with histologic abnormalities of the cervix. The options for management of cervical intraepithelial neoplasia 1, 2, and 3 are ranked according to the str...

Jul 1, 2005 Issue
ACOG Guidelines on the Management of Human Papillomavirus Infection [Practice Guidelines]

The American College of Obstetricians and Gynecologists (ACOG) has released guidelines on the clinical management of women with human papillomavirus (HPV) infection.

Nov 15, 2004 Issue
Management of Cervical Cytologic Abnormalities [Article]

The American Society for Colposcopy and Cervical Pathology developed guidelines in 2001 for the management of cervical cytologic abnormalities. The guidelines incorporate the Bethesda System 2001 terminology and data from randomized studies of atypical squamous cells, low-grade intraepithelial lesio...

Apr 1, 2004 Issue
What Is the Best Collection Device for Screening Cervical Smears? [Cochrane for Clinicians]

The combination of an extended-tip spatula with an endocervical brush (Cytobrush) is the most effective method for obtaining cervical cells. Detection of endocervical cells is a good indication of adequate smears and detection of disease.

Nov 15, 2003 Issue
ACOG Releases Guidelines on Cervical Cytology Screening [Practice Guidelines]

The American College of Obstetricians and Gynecologists (ACOG) recently published a clinical management guideline on cervical cytology screening. In the United States, cervical cancer remains the third most common gynecologic malignancy.

Pages: Previous 1 2 3 4 Next

Email Alerts

Don't miss a single issue. Sign up for the free AFP email table of contents.

Sign Up Now